Form 4: scPharmaceuticals CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Rachael Nokes, CFO and Treasurer of scPharmaceuticals Inc., sold 5,235 shares of common stock on January 3, 2025, to cover tax obligations related to vesting restricted stock units.
Summary
- On January 3, 2025, Rachael Nokes, the CFO and Treasurer of scPharmaceuticals Inc., sold 5,235 shares of the company's common stock.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a weighted average price of $3.5587, with individual transactions ranging from $3.48 to $3.62.
- Following the transaction, Nokes directly owns 67,616 shares of scPharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't convey any strong positive or negative sentiment about the company's prospects.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of the company's performance or future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Rule 10b5-1 instruction adopted |
| 01/03/2025 | Date of transaction: sale of common stock |
| 01/07/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.